Uncategorized

4 ovarian cancer candidates to watch: GSK, Allarity and more

Published

on

Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, OSE Immunotherapies and others are advancing their own candidates.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version